Search hospitals > South Carolina > Greenville
Saint Francis Cancer Center
Claim this profileGreenville, South Carolina 29607
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
Conducts research for Adenocarcinoma
186 reported clinical trials
10 medical researchers
Summary
Saint Francis Cancer Center is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Adenocarcinoma and other specialties. Saint Francis Cancer Center is involved with conducting 186 clinical trials across 364 conditions. There are 10 research doctors associated with this hospital, such as Robert D. Siegel, Howland Crosswell, David Griffin, and Albert Attia.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Robert D. SiegelSaint Francis Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
59 reported clinical trials
116 drugs studied
Howland CrosswellSaint Francis Cancer Center4 years of reported clinical research
Studies Lymphoma
Studies Leukemia
17 reported clinical trials
46 drugs studied
David GriffinSaint Francis Cancer Center5 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
8 reported clinical trials
36 drugs studied
Albert AttiaSaint Francis Cancer Center5 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
7 reported clinical trials
32 drugs studied
Clinical Trials running at Saint Francis Cancer Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Cancer
Acute Lymphoblastic Leukemia
Lymphoma
Anal Cancer
Small Cell Lung Cancer
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Francis Cancer Center?
Saint Francis Cancer Center is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Adenocarcinoma and other specialties. Saint Francis Cancer Center is involved with conducting 186 clinical trials across 364 conditions. There are 10 research doctors associated with this hospital, such as Robert D. Siegel, Howland Crosswell, David Griffin, and Albert Attia.